News

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...
Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation ...
Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...
Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...
The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April ...
In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...
With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...
How do TLR agonists work? Toll-like receptors (TLRs) are a family of proteins that play an integral part in the immune system, as they are the first line of defense against pathogens and harmful cells ...
Hepatitis B is a serious liver infection that is caused by the hepatitis B virus (HBV). Around 254 million people live with hepatitis B, and 6000 people are newly infected with viral hepatitis each ...